Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E

Watchlist Manager
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS Logo
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
Watchlist
Price: 11.64 TRY 0.34%
Market Cap: 2.6B TRY
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ANGEN.E Price Targets Summary
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

There are no price targets for ANGEN.E.
ANGEN.E Lowest Forecast
Wall Street Target
Not Available
ANGEN.E Average Forecast
Wall Street Target
Not Available
ANGEN.E Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS Competitors:
Price Targets
EXEL
Exelixis Inc
11% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
31% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
42% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
9% Upside
EXEL
Exelixis Inc
11% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
31% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
42% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
9% Upside
PGEN
Precigen Inc
140% Upside
LENZ
Graphite Bio Inc
119% Upside
CAPR
Capricor Therapeutics Inc
43% Upside
GBIO
Generation Bio Co
474% Upside

Revenue
Forecast

Revenue Estimate
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

Revenue forecast
is not available for
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

Operating Income
Forecast

Operating Income Estimate
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

Operating Income forecast
is not available for
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

Net Income
Forecast

Net Income Estimate
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

Net Income forecast
is not available for
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

See Also

Summary
ANGEN.E intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANGEN.E stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANGEN.E stock valuation using valuation multiples.
Wall Street Estimates
ANGEN.E price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANGEN.E stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANGEN.E's stock price target?
Not Available

ANGEN.E doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 302,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.